Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
about
Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.Systematic review of anti-tumor necrosis factor-alpha therapy for treatment of immune-mediated uveitis.TNF inhibition for ophthalmic indications: current status and outlook.Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients.Refractory necrotizing scleritis successfully treated with adalimumab.Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet's Disease.
P2860
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@en
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@nl
type
label
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@en
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@nl
prefLabel
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@en
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@nl
P2093
P2860
P1476
Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
@en
P2093
C Hernandez-Garcia
J M Benitez Del Castillo
R Lopez-Gonzalez
P2860
P356
10.1080/03009740802366076
P577
2009-01-01T00:00:00Z